Does a rectal cancer of the upper third behave more like a colon or a rectal cancer?

Diseases of the Colon and Rectum

Volumn 53, Issue 5, 2010, Pages 761-770

  Rosenberg, Robert ^a   Maak, Matthias ^a   Schuster, Tibor ^b   Becker, Karen ^c   Friess, Helmut ^a   Gertler, Ralf ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colon and rectal surgery; Colon cancer; Follow up; Outcomes research; Prognosis; Rectal cancer; Surgical oncology

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEMICOLECTOMY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; RECTUM CANCER; RECTUM RESECTION; SIGMOID; TUMOR LOCALIZATION; TUMOR VOLUME; CHI SQUARE DISTRIBUTION; COLON TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRACTICE GUIDELINE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECTUM TUMOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 77951915109     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181cdb25a     Document Type: Article

References (32)

1. Soreide O, Norstein J, Fielding LP, et al. International standardization and documentation of the treatment of rectal cancer. In: Soreide O, Norstein J, eds. Rectal Cancer Surgery. Optimization-Standardization-Documentation. Berlin, Germany: Springer; 1997:405-445.
2. Wittekind C, Greene FL, Henson C, eds. UICC. TNM Classification of Malignant Tumors, 6th ed. New York, NY: John Wiley & Sons; 2002.
3. Tjandra JJ, Kilkenny JW, Buie WD, et al. The Standards Practice Task Force; The American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48:411-423.
4. Nelson H, Petrelli N, Carlin A, et al. National Cancer Institute Expert Panel Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583-596.
5. Pilipshen SJ, Heilweil M, Quan SH, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1984;53:1354-1362.
6. Folkesson J, Birgisson H, Pahlmann L, et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. Ann Surg. 2002;235:449-457.
7. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
8. Bossett JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114-1123.
9. Kapiteijn E, Marijnen C, Nagtegaal ID, et al. Preoperative radio- therapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
10. Van Cutsem E, Dicato M, Haustermans K. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol. 2008;19: vi1-vi8.
11. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
12. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg. 2004;240:260-268.
13. Lopez-Kostner F, Lavery IC, Hool GR, et al. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery. 1998;124:612-618.
14. Schmiegel W, Pox C, Adler G, et al. S3-Guidelines Conference "Colorectal Carcinoma" 2004. Z Gastroenterol. 2004;42:1129-1177.
15. Peeters K C M J, Marijnen C A M, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693-701.
16. Bleday R, Garcia-Aguilar J. Surgical treatment of rectal cancer. In: Wolff BG, Fleshman JW, Beck DE, Pemberton JH, Wexner SD, eds. The ASCRS Textbook of Colon and Rectal Surgery. Berlin, Germany: Springer; 2007:413-436.
17. Schmiegel W, Reinacher-Schick A, Arnold D, et al. Update S3-guideline "colorectal cancer" 2008. Z Gastroenterol. 2008;46:799-840.
18. Polglase AL, McMurrick PJ, Tremayne AB, et al. Local recurrence after curative anterior resection with principally blunt dissection for carcinoma of the rectum and rectosigmoid. Dis Colon Rectum. 2001;44:947-954.
19. Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after neoadjuvant radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol. 2008;97:8-13.
20. Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3026 patients over a 25-year time period. Ann Surg. 2008;248:968-978.
21. Junginger T, Hermanek P. Problems in the treatment of upper rectal carcinoma. Chirurg. 2008;79:327-339.
22. Hainsworth PJ, Egan MJ, Cinliffe WJ. Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancers. Br J Surg. 1997;84:652-656.
23. Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: long-lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23:5644-5650.
24. Bagla N, Schofield JB. Rectosigmoid tumours: should we continue sitting on the fence? Colorectal Dis. 2007;9:606-608.
25. Park IJ, Choi GS, Lim KH. Different patterns of lymphatic spread of sigmoid, rectosigmoid, and rectal cancers. Ann Surg Oncol. 2008;15:3478-3483.
26. Leong A F P K. Selective total mesorectal excision for rectal cancer. Dis Colon Rectum. 2000;43:1237-1240.
27. Bokey EL, Öjerskog B, Chapuis PH, et al. Local recurrence after curative resection of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg. 1999;86:1164-1170.
28. Eriksen MT, Wibe A, Haffner J, et al. Prognostic groups in 1, 676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum. 2006;50:156-167.
29. Merkel S, Meyer T, Göhl J, et al. Late locoregional recurrence in rectal carcinoma. Eur J Surg Oncol. 2002;28:716-722.
30. Nesbakken A, Njgaard K, Westerheim O, et al. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol. 2002;28:126-134.
31. Hansen MH, Kjaeve J, Revhaug A, et al. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007;94:113-118.
32. Bakx R, Emous M, Legemate DA, et al. Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas. Eur J Surg Oncol. 2006;32:520-526.